GS LHF 75 mg (Tafinlar 75 mg)

Generic Name: dabrafenib

Pill imprint GS LHF 75 mg has been identified as Tafinlar 75 mg.

Tafinlar is used in the treatment of melanoma, metastatic and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tafinlar 75 mg Unknown

See also related documents.

Images for GS LHF 75 mg (Tafinlar 75 mg)

Tafinlar 75 mg GS LHF 75 mg
Tafinlar
Generic Name:
dabrafenib
Imprint:
GS LHF
75 mg
Strength:
75 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
U - Unknown
Manufacturer:
GlaxoSmithKline

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web4)